Impact of prenatal arsenic exposure on chronic adult diseases
- 6 June 2018
- journal article
- review article
- Published by Taylor & Francis in Systems Biology in Reproductive Medicine
- Vol. 64 (6) , 469-483
Abstract
Exposure to environmental stressors during susceptible windows of development can result in negative health outcomes later in life, a concept known as the Developmental Origins of Health and Disease (DOHaD). There is a growing body of evidence that exposures to metals early in life (in utero and postnatal) increase the risk of developing adult diseases such as cancer, cardiovascular disease, non-alcoholic fatty liver disease, and diabetes. Of particular concern is exposure to the metalloid arsenic, a drinking water contaminant and worldwide health concern. Epidemiological studies of areas with high levels of arsenic in the drinking water, such as some regions in Chile and Bangladesh, indicate an association between in utero arsenic exposure and the development of adult diseases. Therefore, the need for experimental models to address the mechanism underlining early onset of adult diseases have emerged including the in utero and whole-life exposure models. This review will highlight the epidemiological events and subsequent novel experimental models implemented to study the impact of early life exposure to arsenic on the development of adult diseases. In addition, current research using these models will be discussed as well as possible underlying mechanism for the early onset of disease. Abbreviations: ALT: alanine aminotransferase; AMI: acute myocardial infarction; AST: aspartate aminotransferase; ATSDR: Agency for Toxic Substances and Disease Registry; CVD: cardiovascular disease; DMA: dimethylarsinate; DOHaD: Developmental Origins of Health and Disease; EPA: U.S. Environmental Protection Agency; ER-α: estrogen receptor alpha; HDL: high-density lipoprotein; HOMA-IR: homeostatic model assessment of insulin resistance; iAs: inorganic arsenic; LDL: low-density lipoprotein; MetS: metabolic syndrome; MMA: monomethylarsonate; NAFLD: non-alcoholic fatty liver disease; PND: postnatal day; ppb: parts per billion; ppm: parts per million; SAM: S-adenosylmethionine; USFDA: United States Food and Drug AdministrationKeywords
Funding Information
- American Diabetes Association (1-18-IBS-02)
- National Institute of Environmental Health Sciences (R21ES023627, R01ES027778)
This publication has 123 references indexed in Scilit:
- Arsenic Binding to ProteinsChemical Reviews, 2013
- Renal, hepatic, pulmonary and adrenal tumors induced by prenatal inorganic arsenic followed by dimethylarsinic acid in adulthood in CD1 miceToxicology Letters, 2012
- Chronic subhepatotoxic exposure to arsenic enhances hepatic injury caused by high fat diet in miceToxicology and Applied Pharmacology, 2011
- Environmental contingency in life history strategies: The influence of mortality and socioeconomic status on reproductive timing.Journal of Personality and Social Psychology, 2011
- Lung function in adults following in utero and childhood exposure to arsenic in drinking water: preliminary findingsInternational Archives of Occupational and Environmental Health, 2010
- Inorganic arsenic as a developmental toxicant: In utero exposure and alterations in the developing rat lungsMolecular Nutrition & Food Research, 2009
- In utero and postnatal exposure to arsenic alters pulmonary structure and functionToxicology and Applied Pharmacology, 2009
- Aberrant DNA methylation and gene expression in livers of newborn mice transplacentally exposed to a hepatocarcinogenic dose of inorganic arsenicToxicology, 2007
- In utero arsenic exposure induces early onset of atherosclerosis in ApoE−/− miceReproductive Toxicology, 2007
- Initial sequencing and comparative analysis of the mouse genomeNature, 2002